Importance of potent P2Y12 receptor blockade in acute myocardial infarction: focus on prasugrel

Author： Jeong Young-Hoon   Tantry Udaya S   Gurbel Paul A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.12, 2012-08, pp. : 1771-1796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Prasugrel, a Novel P2Y 12 Receptor Antagonist, in the Management of Acute Coronary Syndromes

By Baker William L.   White C. Michael  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 213-229

Adis International

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J   Suryadevara Siva   Capranzano Piera   Bass Theodore A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists

By  

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1805-1812

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin receptor blockers in acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 427-430

Informa Healthcare

Access to resources Recommend Favorite

Effects of Angiotensin Receptor Blockade on Haemodynamics and Gene Expression after Myocardial Infarction

By Gurevich A.K.  

Drugs in R&D, Vol. 3, Iss. 4, 2002-01 ,pp. : 239-249

Adis International

Access to resources Recommend Favorite